This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Insulin can be divided into three types ( JAMA , 2024): Human Analog Biosimilar From 2016 to 2020, insulin analogs and insulin biosimilars were the most commonly used insulin types in the U.S., Diabetes Care , 2020) Between 2014 and 2019, the monthly out-of-pocket cost for insulin users with insurance coverage rose from $49 to $58.
He gives the examples of a person with a kidney condition being unable to take ibuprofen , or sumatriptan due to a previous heart attack, or rimegepant due to insurance coverage. Hentrich says healthcare providers prescribe prednisone “if a patient is unable to take common medications prescribed for acute migraine treatment.”
However, the retail price of about $689 for 30, 75 mg tablets of brand-name Gemtesa tablets can be prohibitively expensive without insurance coverage or coupons. “Gemtesa was FDA approved in 2020, so we likely won’t see a generic available until the early 2030s unless a patent challenge or licensing deal accelerates the timeline.”
Additional considerations for selection between oral cephalosporin agents include differences in bioavailability and absorption, specific site of infection and the ability of drug to concentrate at that site, local resistance patterns, insurance coverage, available formulations, and cost to the patient. Arthritis Care Res ( Hoboken ).
While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress. link] NHS England.
The first one was introduced on September 13, 2020, near the end of Trump’s first term, but was shut down by a federal judge due to the administration’s failure to comply with the proper implementation processes. Second, it does not address the core issues of higher prices, such as the use of rebates by insurers. September 13, 2020.
CDC, 2024) Between 2020 and 2021, there were two to three times more males than females who died from an opioid-related overdose. Morbidity and Mortality Weekly Report , 2021) Based on employer-sponsored health insurance data, individuals with OUD paid almost $12,000 in medical bills in 2018.
A monthly supply of Wegovy can cost more than $1,800 without insurance. However, growing insurance coverage and savings programs are helping to make it more accessible. In the United States, 128 million adults had diagnosed heart disease in 2020. How many Americans use insurance for Wegovy? million deaths.
Both modalities have emerged as the most used platform technologies in developing oligonucleotide-based drugs for CNS disorders since 2020. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51 billion) of these deals. Give your business an edge with our leading industry insights.
A 2020 study linked dopamine in the midbrain to heightened levels of anxiety, and an earlier MIT study found that a dopamine imbalance caused more paranoid behavior in rats. Your healthcare provider can still write a prescription for these medications to help you lose weight, but your health insurance may not cover them for off-label use.
The European average time between market authorisation and patient access between 2020 and 2024 was defined according to the time (in days) between approval and pricing as well as the time (in days) between approval and reimbursement. These three markets have seen time to reimbursement increase by 83%, 27%, and 32%, respectively, since 2020.
Utilization of HER2 therapies is positively associated with private insurance, academic facility treatment, and recent diagnosis years. Disparities in HER2 therapy access are linked to rural treatment, Black race, Medicare insurance, and older age. 3 Among the patients, approximately 75.8% 3 Among the patients, approximately 75.8%
In a move towards transparency, the US Food and Drug Administration (FDA) has published more than 200 archived complete response letters (CRLs), which detail reasons for non-approval of drug applications submitted between 2020 and 2024. Give your business an edge with our leading industry insights.
For example, a clinical notation that patient prefers compounded version because insurance will not pay is not acceptable. Updated May 6, 2020. Importantly, the determination must be made by the prescriber and not by the patient’s request. Accessed June 9, 2025. link] FDA Drug Shortages. Updated December 19, 2024.
In fact, people with obesity have a 55% higher chance of developing depression, while people diagnosed with depression have a 58% higher chance of developing obesity, according to a study from 2020. Wellbutrin: Comparison Phentermine Wellbutrin (bupropion) Drug class Anorectic Antidepressant Standard dosage and forms 1537.5
from 2017 to 2020. Authors of a Journal of the American Medical Association study found that adolescent use of GLP-1s “increased substantially” between 2020 and 2023. Dispensing of glucagon-like peptide-1 receptor agonists to adolescents and young adults, 2020-2023. April 2, 2024. Accessed June 25, 2025. 2024;331(23):2041–2043.
2020) The prevalence of functional constipation in children aged 0-18 is 9.5%, and geographical location, lifestyle factors, and stressful life events influence it. ( SingleCare , 2025) Around 91% of Linzess prescriptions have an out-of-pocket cost of $0-$50 per month for people with private health insurance. Mayo Clin Proc.
PCMA unanimous Supreme Court decision in 2020, which allowed states to regulate PBMs, the big health insurance companies and their PBM lobby have been barnstorming the country putting up one legal challenge after another.
Since 2008, the Association of Chemistry and Pharmacy of Uruguay has played an active role in promoting a National Health Surveillance Agency, and in 2020 the government attempted to launch a similar agency but it ultimately failed. Since this setback, the pharmaceutical sector has continued to operate with limited restrictions.
Founded in 2020, Scorpion raised $420m in the next five years while partnering with several pharmaceutical firms and producing six development candidates, three of which are now undergoing clinical trials. Give your business an edge with our leading industry insights.
Blenrep originally won FDA approval in 2020 to treat multiple myeloma. The drugmaker is also seeking a positive decision for the antibody-drug conjugate (ADC) used in combo with Bristol Myers Squibb’s Pomalyst and dexamethasone in the same proposed patient group. Give your business an edge with our leading industry insights.
Licensing deals between US and Chinese biopharma companies hit record highs last year, a 280% increase from 2020, according to analysis by GlobalData. Despite economic pressures, licensing promising drug candidates from Chinese biotechs is becoming a well-trodden path for many US big pharma companies.
Following a 2020 agreement, Biogen has the exclusive licence to develop and commercialise Zurzuvae outside the US, excluding Japan, Taiwan, and South Korea. The acquisition affords Supernus a dominant position in the market. Co-developed with Biogen, Zurzuvae earned Sage $36.1m in sales in 2024 and $13.8m in Q1 2025.
Licensing deals between US and Chinese biopharma companies hit record highs last year, up 280% from 2020, according to analysis by GlobalData. Across big pharma, transactions rose 66% from $16.6bn in 2023 to $41.5bn in 2024, demonstrating that China is still the go-to place to discover pipeline candidates.
By GlobalData Learn more about Strategic Intelligence Blenrep was approved under the FDA accelerated approval process in 2020 to treat multiple myeloma (MM). Stay proactive with real-time data and expert analysis. Give your business an edge with our leading industry insights.
Being able to examine how the initial choice of supplemental insurance relates to plan switching is critical in order to ensure that those with high-cost health conditions have access to adequate and affordable coverage. The main outcome being measured was self-reported switching in the two years after one’s original Medicare plan choice.
billion on dietary supplements in 2020 alone. National Institutes of Health , 2021) How many Americans use insurance for vitamin D supplements ? When taken as a supplement without a prescription, Vitamin D is typically not covered by insurance. How many Americans pay for vitamin D out of pocket?
based Sutter want to be repaid for the money they spent on health insurance from 2011 through 2020. Terms of the settlement were not immediately released on Monday, but it’s likely sizable given the scope of the case. The individuals and businesses suing Sacramento, Calif.-based
While reimbursement remains a challenge, the Centers for Medicare and Medicaid Services and private insurers are starting to look into value-based models that incorporate nutrition counseling. 13510 Nutrition Counseling Coverage Act of 2021, HR 6971, 116th Cong (2019-2020). J Clin Pharm Ther. 2022;47(1):45-52. doi:10.1111/jcpt.13510
With the goal of determining obesity-related mortality during the study period, researchers explored age-adjusted mortality rates (AAMRs) for 3 timeframes within the COVID-19 pandemic: pre-pandemic (2018-2019), COVID-19 (2020-2021), and post-pandemic (2022-2023).
The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.
Meanwhile, the radiologist’s office contacts your insurance to get the service approved. Your insurance provider decided to deny the claim, which means you can’t have the scan. Or, worst-case scenario, you’ve already gotten it and your insurance denied the claim after the fact. What is an insurance appeal letter?
The latest rollout of Covid-19 vaccines has been messy, with people facing more challenges getting one of the updated shots than they may have experienced since the frantic start of the very first vaccination campaign in late 2020 and the first half of 2021.
In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer that had metastasized into some of his bones. He welcomed the treatment, but was surprised by the $740 monthly copay cost, even after coverage from Medicare and supplemental insurance. government.
The Department of Justice filed a new lawsuit against Cigna Monday, alleging the health insurance company overcharged the federal government by purposefully inflating how sick its Medicare Advantage members were. Read the rest…
between 2004 and 2020 found that those who had cranial surgery, which involves removing or disconnecting the brain portion where seizures occur, were 83% more likely to be alive after 10 years. The study of 18,000 children who were treated at 49 pediatric hospitals in the U.S.
In theory, they’re supposed to power a basic pain management device she ordered from a company called Zynex Medical in 2020. Before she bought the electrical stimulation unit, Zynex assured her the supplies would be covered by Tufts Health Plan, her insurance company.
What is health insurance? | How common is health insurance? Health insurance stats by ethnicity | Health insurance stats by state | Health insurance stats by age group | Health insurance stats by type | Common complications | Costs | Treatment | FAQs | Research Health insurance is a hot topic these days.
A participant in a 2020 report from the National LGBT Cancer Network said: “There are no guidelines for cancers that are more prevalent among Trans women. Lack of health data on LGBTQ+ people has real-world consequences. I had to fight like hell to have an anoscopy, and sure enough we found [precancerous lesions]!”
Under CEO Laura Perryman’s leadership, the company warped the design of their devices to earn more reimbursement money from insurers, resulting in unnecessary plastic parts that allowed doctors to claim around $18,000 more than they previously could. From 2017 to 2020, the company sold nearly 8,000 devices with the fake component.
Without insurance, Sutab costs $235 for two 12-tablet bottles—the equivalent of one course. Food and Drug Administration (FDA) in 2020, it will be quite some time before a generic version becomes available. Without insurance, a Sutab averages $235 per course. Is Sutab covered by insurance?
Under her leadership, Stimwave warped the design of the device to better align with insurance codes, resulting in unnecessary plastic components that allowed the company to sell their products for thousands of dollars more than they otherwise could. From 2017 to 2020, the company implanted nearly 8,000 patients with these devices.
Without insurance, the average cost of Novolog is $143 for one 3 mL pen of 100 units/mL. In 2020 , Novo Nordisk launched an authorized generic of Novolog that was available at a 50% discount compared to its brand-name version. Without insurance, the average retail price of insulin aspart is $217 for one 10 mL vial of 100 units/mL.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content